ZNF584 employ various intracellular signaling mechanisms to modulate its functional activity through phosphorylation. Phorbol 12-myristate 13-acetate (PMA) and its analog TPA directly activate protein kinase C (PKC), a family of enzymes that can phosphorylate ZNF584, enhancing its activity. Activation of PKC by these agents induces a cascade of events that lead to the modification of target proteins such as ZNF584, which may alter its binding affinity to DNA or interaction with other proteins. Similarly, Forskolin and Dibutyryl-cAMP (db-cAMP) elevate intracellular cAMP levels, which in turn activate protein kinase A (PKA). PKA then phosphorylates various substrates, including potentially ZNF584, influencing its function.
Ionomycin, by increasing intracellular calcium levels, activates calcium-dependent protein kinases capable of phosphorylating ZNF584. Thapsigargin also disrupts calcium homeostasis and can indirectly lead to the activation of ZNF584 through the same calcium-dependent pathways. In the realm of growth factors, Epidermal Growth Factor (EGF) engages its receptor and activates the EGFR tyrosine kinase signaling pathway, which can result in the phosphorylation of a range of proteins. ZNF584 may be among these proteins if it is positioned downstream in this signaling cascade. Insulin stimulates its receptor pathway, leading to the activation of kinases such as AKT, which may also target ZNF584 for phosphorylation. Stress conditions induced by Anisomycin trigger the activation of stress-activated protein kinases (SAPKs) such as JNK, which can phosphorylate various transcription factors and possibly ZNF584, altering its functional state. Lastly, inhibitors of protein phosphatases like Calyculin A and Okadaic Acid prevent dephosphorylation, thereby sustaining the phosphorylated state of proteins including ZNF584. BAY 11-7082 intervenes in NF-κB signaling, causing changes in phosphorylation patterns within the cell that could also impinge on the functional activity of ZNF584. Through these diverse mechanisms, chemical activators manipulate the phosphorylation status of ZNF584, modulating its activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which in turn can phosphorylate various proteins including ZNF584. The phosphorylation by PKC can lead to an increase in the functional activity of ZNF584. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels which can activate calcium-dependent protein kinases. These kinases can phosphorylate and thereby upregulate the functional activity of proteins such as ZNF584. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor signaling pathway, leading to the activation of multiple downstream kinases, such as AKT, which could phosphorylate and thereby activate ZNF584 directly or indirectly. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, leading to an increase in the phosphorylation state of proteins. This could increase the phosphorylation and activation of ZNF584. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, Okadaic Acid inhibits protein phosphatases, which could result in increased phosphorylation and activation of ZNF584. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs) like JNK, which could phosphorylate transcription factors and potentially ZNF584, leading to its activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis and can activate calcium-dependent signaling pathways, potentially leading to the activation of ZNF584 through phosphorylation by calcium-dependent kinases. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can phosphorylate a wide range of proteins, potentially including ZNF584, leading to its functional activation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-κB activation, which can lead to altered phosphorylation patterns in the cell, potentially upregulating the functional activity of ZNF584 through changes in kinase and phosphatase activity. | ||||||